✦ LIBER ✦

Overcoming nucleoside analog chemoresistance of pancreatic cancer: A therapeutic challenge

✍ Scribed by Sau Wai Hung; Hardik R. Mody; Rajgopal Govindarajan

Book ID: 116335887
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 468 KB
Volume: 320
Category: Article
ISSN: 0304-3835
DOI: 10.1016/j.canlet.2012.03.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolic limitations of the use of nucl

Metabolic limitations of the use of nucleoside analogs in cancer therapy may be overcome by application of nanoparticles as drug carriers: A review

✍ Lukasz Hajdo; Aleksandra Beata Szulc; Barbara Klajnert; Maria Bryszewska 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

## Abstract Purine and pyrimidine nucleoside analogs (NAs) are antimetabolites commonly used in cancer therapy. Administered as prodrugs, NAs permeate the mambrane using specialized transporters. Following phosphorylation, they interfere with multiple cellular pocessess inducing cytotoxicity. Toxic

Mucin impedes cytotoxic effect of 5-FU a

Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain

✍ Kalra, A V; Campbell, R B 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 348 KB